Lobbying

Object Pharma's latest lobbying report covers Q2 2026, at $10K. The four quarters Q4 2025–Q3 2026 total $30K. Its first report covers Q4 2024; the issues it reports most are Health Issues and Veterans.

Object Pharma

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$30K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2024
The first quarter a report named it

Lobbying by quarter

Object Pharma lobbying by quarter
Object Pharma lobbying by quarter
QuarterAmountReports
Q4 2024$5,0001
Q1 2025$10K1
Q2 2025$10K1
Q3 2025$10K1
Q4 2025$10K1
Q1 2026$10K1
Q2 2026$10K1
Q3 2026$00

By issue

  • Health issues$32.5K · 7 reports
  • Veterans$32.5K · 7 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES7 reports
  • SENATE7 reports

Firms it paid

Firm
Eagle Point Strategies$65K7 quarters

Former officials lobbying for it

Former position
CLAY WHITEChief of Staff, Leg Director - Congressman Chris Stewart; Leg Director, Leg Asst - Congressman Jason ChaffetzQ2 2026

Lobbying reports

Filed by
07/08for Q2Eagle Point Strategies$10K
04/13for Q1Eagle Point Strategies$10K
01/14for Q4 2025Eagle Point Strategies$10K
25/10/13for Q3 2025Eagle Point Strategies$10K
25/07/12for Q2 2025Eagle Point Strategies$10K
25/04/09for Q1 2025Eagle Point Strategies$10K
25/01/09for Q4 2024Eagle Point Strategies$5,000
24/11/15for Q4 2024Eagle Point StrategiesUnder $5,000